Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2016 1
2017 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer.
Kim JY, Byun SJ, Kim YS, Nam JH. Kim JY, et al. Gynecol Oncol. 2017 Jan;144(1):34-39. doi: 10.1016/j.ygyno.2016.10.032. Epub 2016 Oct 24. Gynecol Oncol. 2017. PMID: 27789082
OBJECTIVE: To investigate the disease course and identify prognostic factors for survival in patients with residual disease according to post-treatment magnetic resonance imaging (MRI) following definitive concurrent chemoradiot
OBJECTIVE: To investigate the disease course and identify prognostic factors for survival in patients with residual
Segmentary ureteral resection followed by ureteroneocystostomy associated with radical hysterectomy and partial cystectomy in a patient with bulky residual disease after chemoirradiation for invasive cervical cancer--a case report.
Bacalbaşa N, Bălescu I. Bacalbaşa N, et al. J Med Life. 2014 Oct-Dec;7(4):558-62. J Med Life. 2014. PMID: 25713622 Free PMC article.
Cervical cancer represents the second most frequent malignancy in women worldwide, a significant number of cases still being diagnosed in an advanced stage of the disease. ...In these cases, more aggressive surgical procedures are needed in order to ob
Cervical cancer represents the second most frequent malignancy in women worldwide, a significant number of cases still being d
Response to neoadjuvant chemotherapy with paclitaxel and cisplatin in locally advanced cervical cancer.
Mousavia AS, Vahidi S, Karimi-Zarchi M, Modarress-Gilania M, Ghaemmaghamia F. Mousavia AS, et al. Eur J Gynaecol Oncol. 2013;34(6):527-31. Eur J Gynaecol Oncol. 2013. PMID: 24601044 Clinical Trial.
PURPOSE: The purpose of this study was to evaluate the efficacy and toxicity of paclitaxel and cisplatin as neoadjuvant chemotherapy for patients with Stage IB2 to IIB cervical cancer and determine factors accountable for response. MATERIALS AND METHODS: From …
PURPOSE: The purpose of this study was to evaluate the efficacy and toxicity of paclitaxel and cisplatin as neoadjuvant chemotherapy for …